[Form 4] Iridex Corp Insider Trading Activity

Rhea-AI Filing Summary

Romeo R. Dizon, Chief Financial Officer of Iridex Corp (IRIX), reported multiple open-market purchases totaling 1,005 shares on 08/28/2025. The transactions executed at prices between $1.325 and $1.36 per share increased his direct beneficial ownership from 50,745 shares to 51,750 shares. Individual purchases reported: 50 shares at $1.33, 200 shares at $1.325, 250 shares at $1.35 and 505 shares at $1.36. The Form 4 was signed by an attorney-in-fact on 08/29/2025. No derivative transactions were reported and no additional explanatory text was provided.

Positive

• CFO increased direct ownership by 1,005 shares, rising to 51,750 shares, which aligns management interest with shareholders
• Transparent disclosure: Form 4 reports transaction dates, share counts, and prices, and is properly signed

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider purchases totaling 1,005 shares at low single-digit dollar prices modestly increased CFO ownership; routine disclosure, limited market impact.

These are straightforward, small open-market acquisitions by the company's CFO reported on Form 4. The total outlay (~$1,350) is immaterial relative to typical market-cap metrics and does not indicate a major change in control or financing. For investors, the filing primarily documents insider accumulation but is unlikely to move valuation metrics or signal a material change in corporate strategy given the size.

Corporate Governance Expert

TL;DR: Properly filed Form 4 documenting direct purchases by an officer; no governance red flags present in the disclosure.

The Form 4 lists the reporting person, relationship (CFO), transaction dates, codes, share counts, and prices, and is signed by an attorney-in-fact. There are no amendments, derivative transactions, or indications of Rule 10b5-1 plans checked. From a governance perspective, the filing meets disclosure requirements and raises no immediate compliance concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/28/2025		P		50	A	$1.33	50,795	D
Common Stock	08/28/2025		P		200	A	$1.325	50,995	D
Common Stock	08/28/2025		P		250	A	$1.35	51,245	D
Common Stock	08/28/2025		P		505	A	$1.36	51,750	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	08/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What trades did IRIX CFO Romeo R. Dizon report on Form 4?

He reported four open-market purchases on 08/28/2025 totaling 1,005 shares at prices of $1.325, $1.33, $1.35, and $1.36 per share.

How many IRIX shares does Romeo R. Dizon own after the reported transactions?

Following the reported purchases, his direct beneficial ownership is 51,750 shares.

Were any derivative securities (options, warrants, etc.) reported for IRIX in this filing?

No. Table II for derivative securities contains no reported transactions in this Form 4.

When were the transactions and who signed the Form 4?

Transactions occurred on 08/28/2025 and the Form 4 was signed by an attorney-in-fact, Nilo De Castro, on 08/29/2025.

Do these purchases indicate a material change in control or strategy at IRIX?

The filing shows small open-market purchases by the CFO totaling 1,005 shares; the document contains no indication of changes in control or strategy.